BMGL (Basel Medical Group Ltd Ordinary Shares) Stock Analysis - Politician Trades

Basel Medical Group Ltd Ordinary Shares (BMGL) is a publicly traded Healthcare sector company. As of May 21, 2026, BMGL trades at $0.63 with a market cap of $12.39M and a P/E ratio of 0.00. BMGL moved +0.00% today. Year to date, BMGL is +9.49%; over the trailing twelve months it is -67.59%. Its 52-week range spans $0.49 to $9.40. Rallies surfaces BMGL's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Which politicians traded BMGL stock?

Rallies tracks politician and congressional stock disclosures for BMGL, including purchases, sales, transaction dates, owners, and reported trade amounts when available.

BMGL Key Metrics

Key financial metrics for BMGL
MetricValue
Price$0.63
Market Cap$12.39M
P/E Ratio0.00
EPS$0.00
Dividend Yield0.00%
52-Week High$9.40
52-Week Low$0.49
Volume2
Avg Volume0
Revenue (TTM)$0
Net Income$0
Gross Margin0.00%

Latest BMGL News

BMGL Analyst Consensus

BMGL analyst coverage data. Average price target: $0.00.

Common questions about BMGL

Which politicians traded BMGL stock?
Rallies tracks politician and congressional stock disclosures for BMGL, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
Does Rallies track congressional trades in BMGL?
Yes. Rallies tracks politician and congressional stock disclosures for BMGL, including reported purchases, sales, dates, owners, and trade amounts when available.
Is BMGL research on Rallies investment advice?
No. Rallies provides research, data, and educational context for BMGL. It does not provide personalized investment advice.
BMGL

BMGL